ANTENGENE CORPORATION LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.77 HKD | -1.28% |
|
-3.70% | -61.00% |
| 06-26 | Antengene Announces XPOVIO® National Health Insurance Service Approval for Reimbursement in South Korea | CI |
| 05-02 | Antengene Logs Slimmer Loss in 2023 Despite Revenue Drop | MT |
Evolution of the average Target Price on Antengene Corporation Limited
Price target over the last 5 years
History of analyst recommendation changes
9158bd5cd3643da8ee04b.tDwuubD1fj8kukraw0658ZfMqb_dp5oDKQxDNpBWQyw.4lUbi-mdP2h26RKeigTMtMT6-8y-wPhmBD8tVakDGWbYDWDTgK86XROMOQ~5bd1bed906440be96bb8b49b5652af7d
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.7259
CNY
Average target price
1.666
CNY
Spread / Average Target
+129.57%
High Price Target
1.858
CNY
Spread / Highest target
+155.95%
Low Price Target
1.475
CNY
Spread / Lowest Target
+103.19%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 6996 Stock
- Consensus Antengene Corporation Limited
